Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Kanoko Sawafuji"'
Autor:
Hiroaki Okamoto, Koshiro Watanabe, Hiroshi Kunikane, Kanoko Sawafuji, Nobuo Nakamura, Akira Nagatomo
Publikováno v:
Internal Medicine. 39:478-481
We present a rare case of a five-year survivor of small cell lung cancer with severe complications who responded to combined modality treatment. Prior to initial chemotherapy, he experienced severe complications including sepsis, pneumonia, ileus, an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2916f2439d93033f01fa2f32a985c717
https://doi.org/10.2169/internalmedicine.39.478
https://doi.org/10.2169/internalmedicine.39.478
Autor:
Yoshitaka Miyakawa, James D. Griffin, Masahiro Kizaki, Yasuo Ikeda, Ellen Weisberg, Kanoko Sawafuji
Publikováno v:
Leukemialymphoma. 44(11)
A tyrosine kinase inhibitor, STI571, has been demonstrated to be effective for the treatment of chronic myelogenous leukemia (CML). STI571 inhibits tyrosine kinase activity of ABL and induces apoptosis of CML cells. However, drug resistance develops
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9188dcb7413ffae4e2d5f08cba1a5d08
https://pubmed.ncbi.nlm.nih.gov/14738154
https://pubmed.ncbi.nlm.nih.gov/14738154
Publikováno v:
American journal of hematology. 72(1)
We studied the effects of cyclosporin A (CsA) on the erythroid differentiation of human erythroid leukemia cell line K562. After K562 was treated with CsA for 4 days, the percentage of hemoglobinized cells was increased by 3.3 times. Because it was r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be81986eea6c408f0972882879091174
https://pubmed.ncbi.nlm.nih.gov/12508271
https://pubmed.ncbi.nlm.nih.gov/12508271